Takeaway
- A new meta-analysis finds that treating patients with selective serotonin reuptake inhibitors (SSRIs) after stroke improves most measures of recovery.
Why this matters
- A 2018 Cochrane meta-analysis found little benefit of SSRIs.
Key results
- Benefits of SSRIs vs placebo:
- Preventing depression (weighted mean difference [WMD], −7.05; 95% CI, −11.78...